LSA
DGX icon

Leonteq Securities AG’s Quest Diagnostics DGX Stock Holding History

Leonteq Securities AG’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97K Sell
14
-37
-73% -$7.26K ﹤0.01% 1126
2026
Q1 		$9.99K Buy
51
+50
+5,000% +$9.71K ﹤0.01% 1069
2025
Q4 		$174 Hold
1
– – ﹤0.01% 1401
2025
Q3 		$191 Sell
1
-159
-99% -$28.2K ﹤0.01% 1290
2025
Q2 		$28.7K Hold
160
– – ﹤0.01% 935
2025
Q1 		$27.1K Buy
160
+143
+841% +$23.5K ﹤0.01% 932
2024
Q4 		$2.56K Sell
17
-8
-32% -$1.24K ﹤0.01% 1146
2024
Q3 		$3.88K Hold
25
– – ﹤0.01% 1056
2024
Q2 		$3.42K Sell
25
-3
-11% -$411 ﹤0.01% 1077
2024
Q1 		$3.73K Buy
+28
New +$3.63K ﹤0.01% 1107
2023
Q3 		– Sell
-641
Closed -$90.1K – 1223
2023
Q2 		$90.1K Buy
+641
New +$88.4K ﹤0.01% 700
2022
Q2 		– Sell
-4
Closed -$547 – 1293
2022
Q1 		$547 Sell
4
-11
-73% -$1.53K ﹤0.01% 1207
2021
Q4 		$2.6K Sell
15
-346
-96% -$52.6K ﹤0.01% 1209
2021
Q3 		$52.5K Buy
361
+329
+1,028% +$48.1K ﹤0.01% 840
2021
Q2 		$4.22K Sell
32
-13
-29% -$1.7K ﹤0.01% 1027
2021
Q1 		$5.78K Sell
45
-24
-35% -$2.96K ﹤0.01% 944
2020
Q4 		$8.22K Buy
+69
New +$8.41K ﹤0.01% 918

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Leonteq Securities AG's DGX Position: Q2 2026 in Review

Leonteq Securities AG reduced its Quest Diagnostics (DGX) stake by 73% in Q2 2026, selling an estimated $7.26K and leaving 14 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

Leonteq Securities AG first reported a position in DGX in Q4 2020 and has held it in 17 quarters since. The position peaked at $90.1K in Q2 2023. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Leonteq Securities AG held 14 shares of Quest Diagnostics worth $2.97K as of Q2 2026.
  • Leonteq Securities AG sold 37 Quest Diagnostics shares in Q2 2026, an estimated $7.26K.
  • Quest Diagnostics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1126 holding.
  • Leonteq Securities AG first reported a position in Quest Diagnostics in Q4 2020 and has held it in 17 quarters since.
  • Leonteq Securities AG's Quest Diagnostics position peaked at $90.1K in Q2 2023.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.